Design Therapeutics, Inc. - DSGN

SEC FilingsOur DSGN Tweets

About Gravity Analytica

Recent News

  • 09.10.2025 - Design Therapeutics Appoints Justin Gover to Board of Directors
  • 09.10.2025 - Design Therapeutics Appoints Justin Gover to Board of Directors
  • 09.04.2025 - Cantor Global Healthcare Conference 2025
  • 09.04.2025 - Cantor Global Healthcare Conference 2025
  • 08.27.2025 - Design Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
  • 08.27.2025 - Design Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
  • 08.07.2025 - Design Therapeutics Highlights Progress Across Lead GeneTACĀ® Programs and Reports Second Quarter 2025 Financial Results
  • 08.07.2025 - Design Therapeutics Highlights Progress Across Lead GeneTACĀ® Programs and Reports Second Quarter 2025 Financial Results

Recent Filings

  • 09.10.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.10.2025 - 3 Initial statement of beneficial ownership of securities
  • 09.10.2025 - 8-K Current report
  • 08.28.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 08.14.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.13.2025 - 144 Report of proposed sale of securities
  • 08.13.2025 - 144 Report of proposed sale of securities
  • 08.07.2025 - 8-K Current report
  • 08.07.2025 - EX-99.1 EX-99.1
  • 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]